Fonar Corporation news

   Watch this stock
Showing stories 1 - 10 of about 73   

Articles published

FONR 16.13 -0.02 (-0.12%)
price chart
Fonar Corporation (NASDAQ:FONR) Impact Score At 75
Alpha One explored various online articles released on Fonar Corporation (NASDAQ:FONR), and it set a daily sentiment score of 0.505 on the company.
Fonar Corp. (FONR) Names Timothy Damadian President/CEO
FONAR Corporation (NASDAQ: FONR) announced today that effective February 11, 2016, Timothy Damadian, the elder son of Dr. Raymond V. Damadian, has been named President and Chief Executive Officer of FONAR Corporation. Dr. Damadian, the ...
Fonar Corporation: FONAR Announces 3rd Quarter and Nine Months Financial ...
MELVILLE, NEW YORK, May 10, 2016 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, reported its fiscal 2016 third quarter and nine-months results for the period ended March 31, 2016.
FONAR Reports Higher Q3 Profit, Revenue (NASDAQ:FONR)  Sonoran Weekly Review
Fonar: Not Too Many Reasons To Be A Buyer Anymore
And while the diagnostic business is doing well and has been able to fill in the lower MRI sales gap, the truth of the matter is that, for me at least, MRI sales are the most important factor in determining if I would want to be a shareholder in this ...
Fonar: A Micro-Cap With 40% Upside (FONR)
Fonar is a pioneer in MRI machines, and currently markets the unique Upright MRI system. The company's current growth strategy has been successful and is plausible moving forward.
Fonar: A Micro-Cap With 40% Upside (registration)
Fonar Corporation (NASDAQ:FONR) Basic Consolidated EPS At $2.3983
The yearly basic consolidated EPS for Fonar Corporation (NASDAQ:FONR) for the period ended 2015-06-30 was $2.3983. For the quarter ended 2015-06-30 the basic consolidated EPS was $2.3983.
Fonar - Unknown And Undervalued
Fonar Corporation (NASDAQ:FONR) is engaged in the research, development, productions, and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection of and diagnosis of human diseases.
Related articles »  
Fonar Corporation (NASDAQ:FONR) Shorted Shares Decreased By 34.53%
The stock of Fonar Corporation (NASDAQ:FONR) registered a decrease of 34.53% in short interest. FONR's total short interest was 14,600 shares in May as published by FINRA.
Fonar Is An Unusual And Undervalued Play On The Obesity Epidemic (FONR)
Fonar Corp. (NASDAQ:FONR) is an undervalued stock in the medical field that will benefit from the obesity epidemic in the United States and abroad in an unusual way.
Related articles »  
Fonar: At Last, Light At The End Of The Tunnel?
This company was always on the verge of something exciting, but could never get its act together. For example, Raymond Damadian, M.D.